WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 39 filers reported holding WEREWOLF THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,341,373 | -29.8% | 626,810 | 0.0% | 0.24% | -18.4% |
Q2 2023 | $1,911,771 | +17.3% | 626,810 | 0.0% | 0.30% | +9.9% |
Q1 2023 | $1,629,706 | +26.8% | 626,810 | 0.0% | 0.27% | -1.4% |
Q4 2022 | $1,284,961 | -54.5% | 626,810 | 0.0% | 0.28% | -29.6% |
Q3 2022 | $2,827,000 | +15.8% | 626,810 | +5.0% | 0.39% | +50.2% |
Q2 2022 | $2,442,000 | -5.0% | 597,003 | +2.2% | 0.26% | -28.1% |
Q1 2022 | $2,570,000 | -66.7% | 584,203 | -9.9% | 0.36% | -57.2% |
Q4 2021 | $7,722,000 | -34.6% | 648,391 | -5.8% | 0.85% | -14.5% |
Q3 2021 | $11,814,000 | -2.0% | 688,475 | -2.5% | 0.99% | +21.8% |
Q2 2021 | $12,049,000 | – | 706,294 | – | 0.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DC Funds, LP | 589,102 | $1,796,761 | 38.27% |
MPM ASSET MANAGEMENT LLC | 4,284,172 | $13,066,725 | 6.41% |
MPM BioImpact LLC | 2,388,011 | $7,283,434 | 1.47% |
RA Capital Management | 6,144,881 | $18,741,887 | 0.35% |
SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,911,771 | 0.30% |
PFM Health Sciences, LP | 2,303,891 | $7,026,868 | 0.27% |
Rubric Capital Management LP | 1,935,357 | $5,902,839 | 0.25% |
Alyeska Investment Group, L.P. | 397,808 | $1,213,314 | 0.01% |
Laurion Capital Management LP | 522,900 | $1,594,845 | 0.01% |
Schonfeld Strategic Advisors LLC | 326,702 | $996,441 | 0.01% |